Cell Reports (Jun 2021)

Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome

  • Duygu Kuzuoglu-Ozturk,
  • Zhiqiang Hu,
  • Martina Rama,
  • Emily Devericks,
  • Jacob Weiss,
  • Gary G. Chiang,
  • Stephen T. Worland,
  • Steven E. Brenner,
  • Hani Goodarzi,
  • Luke A. Gilbert,
  • Davide Ruggero

Journal volume & issue
Vol. 35, no. 13
p. 109321

Abstract

Read online

Summary: The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protein required for translation of all eukaryotic genomes, is a surprising yet potent oncogenic driver. The genetic interactions that maintain the oncogenic activity of this key translation factor remain unknown. In this study, we carry out a genome-wide CRISPRi screen wherein we identify more than 600 genetic interactions that sustain eIF4E oncogenic activity. Our data show that eIF4E controls the translation of Tfeb, a key executer of the autophagy response. This autophagy survival response is triggered by mitochondrial proteotoxic stress, which allows cancer cell survival. Our screen also reveals a functional interaction between eIF4E and a single anti-apoptotic factor, Bcl-xL, in tumor growth. Furthermore, we show that eIF4E and the exon-junction complex (EJC), which is involved in many steps of RNA metabolism, interact to control the migratory properties of cancer cells. Overall, we uncover several cancer-specific vulnerabilities that provide further resolution of the cancer translatome.

Keywords